Blood Tests for Gastritis and Gastric Neoplasms
NCT05883345 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1490
Last updated 2025-03-11
Summary
Helicobacter pylori infection rate is decreasing in younger population; however, biennial gastroscopy is still recommended for all Koreans aged between 40 and 75 years. This study aimed to validate blood tests for gastric cancer screening according to the infection status of H. pylori (naive, current, and past infection).
Conditions
- Cancer Screening Tests
Interventions
- DIAGNOSTIC_TEST
-
Serum blood test for Helicobacter pylori immunoglobulin G, pepsinogen, and gastrin-17 levels
Endoscopic biopsy
Sponsors & Collaborators
-
Konkuk University Medical Center
lead OTHER
Principal Investigators
-
Sun-Young Lee, MD, PhD · Department of Internal Medicine, Konkuk University School of Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-01
- Primary Completion
- 2024-08-30
- Completion
- 2024-08-30
Countries
- South Korea
Study Locations
More Related Trials
-
Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections
NCT02123771 ·Status: UNKNOWN
-
A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA
NCT03057171 ·Status: UNKNOWN
-
Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer
NCT04989153 ·Status: UNKNOWN
-
Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea
NCT02184910 ·Status: UNKNOWN
-
Gastrin, Anti-helicobacter Pylori and Pepsinogen Diagnostic Accuracy Study
NCT07060482 ·Status: NOT_YET_RECRUITING
-
Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test
NCT06943768 ·Status: NOT_YET_RECRUITING
-
Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication
NCT01678027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer
NCT01002443 ·Status: COMPLETED ·Phase: PHASE2
-
Serological Screening of Gastric Cancer in Wuxi Region
NCT02663427 ·Status: UNKNOWN ·Phase: NA
-
The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study
NCT02933229 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Serum Pepsinogen After H. Pylori Eradication
NCT03924375 ·Status: COMPLETED
-
Gastric and Duodenal Microbiota in Dyspeptic Subjects
NCT02542579 ·Status: COMPLETED
-
Screening for Early Gastric Cancer in Shaanxi Province
NCT05291728 ·Status: RECRUITING
-
Association of Oral Helicobacter Pylori Infection With Gastric Helicobacter Pylori Infection
NCT05790512 ·Status: COMPLETED
-
Distribution of Helicobacter Pylori After Gastrectomy
NCT03419936 ·Status: UNKNOWN
-
Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection
NCT06943781 ·Status: RECRUITING
-
Gastropanel for Gastric Atrophy and Cancer Risk Assessment
NCT02114411 ·Status: UNKNOWN
-
Detection of Helicobacter Pylori Infection by High Resolution Endoscopy
NCT01434992 ·Status: COMPLETED
-
Difference of Gastric Microbiota in the Process of Correa's Model.
NCT02833363 ·Status: UNKNOWN
-
Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer
NCT07312500 ·Status: ACTIVE_NOT_RECRUITING
-
Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01)
NCT03597672 ·Status: UNKNOWN
-
Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the Community
NCT03793335 ·Status: ENROLLING_BY_INVITATION
-
Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients
NCT02691637 ·Status: COMPLETED
-
A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
NCT07032961 ·Status: RECRUITING
-
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2
NCT07224048 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4